Furthermore, as autophagy participates in the resistance to tyrosine kinase inhibitor (TKI) treatment, the combination of TKIs with the autophagy inhibitor Lys05 could improve FLT3-ITD AML treatment [138]. The gene discussed is FLT3; the disease is acute myeloid leukemia.